High Drinking in the Dark (HDID) Mice Are Sensitive to the Effects of Some Clinically Relevant Drugs to Reduce Binge-like Drinking

BACKGROUND: There is a serious public health need for better understanding of alcohol use disorder disease mechanisms and for improved treatments. At this writing, only three drugs are approved by the Food and Drug Administration as medications to treat alcohol use disorders – disulfiram, naltrexone...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacol Biochem Behav
Main Authors: Crabbe, John C, Ozburn, Angela R, Metten, Pamela, Barkley-Levenson, Amanda, Schlumbohm, Jason P., Spence, Stephanie E., Hack, Wyatt R, Huang, Lawrence C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5603423/
https://ncbi.nlm.nih.gov/pubmed/28827047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2017.08.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados